Terms: = Pancreatic cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
19 results:
1. Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis.
Jeong H; Lim SY; Jeon HJ; Yoon SJ; Kim H; Han IW; Heo JS; Shin SH
ANZ J Surg; 2023 Nov; 93(11):2655-2663. PubMed ID: 37658597
[TBL] [Abstract] [Full Text] [Related]
2. FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
Kobayashi S; Tezuka S; Yamachika Y; Tsunoda S; Nagashima S; Tozuka Y; Fukushima T; Morimoto M; Ueno M; Furuse J; Maeda S
BMC Cancer; 2023 Feb; 23(1):177. PubMed ID: 36809997
[TBL] [Abstract] [Full Text] [Related]
3. Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score‑matched analysis of 1164 patients.
Gao G; Liao H; Jiang Q; Liu D; Li T
World J Surg Oncol; 2022 Sep; 20(1):315. PubMed ID: 36171631
[TBL] [Abstract] [Full Text] [Related]
4. Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions.
Lu W; Wang L; Lou J; Tang K
Tumori; 2023 Jun; 109(3):307-313. PubMed ID: 35815545
[TBL] [Abstract] [Full Text] [Related]
5. [Minimally invasive enucleation for benign and low-grade malignant pancreatic tumors: an analysis of 60 cases].
Liu MQ; Liu WS; Li Z; Zhuo QF; Ji SR; Xu WY; Shi YH; Yu XJ; Xu XW
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):674-679. PubMed ID: 35775260
[No Abstract] [Full Text] [Related]
6. A study on the antitumor effect of gemcitabine polybutylcy- anoacrylate nanoparticles coupled with Mucin 1 monoclonal antibody on pancreatic cancer
Zhang L; Zhu J; Hou Y; Li C; Liu H
J Cancer Res Ther; 2021 Dec; 17(7):1702-1708. PubMed ID: 35381742
[TBL] [Abstract] [Full Text] [Related]
7. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
[TBL] [Abstract] [Full Text] [Related]
8. [Measurement of PODXL and SCGB1D2 for detecting intraductal papillary mucinous neoplasm].
Taniuchi K; Okabayashi T; Sakaguchi M; Iwata J
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(3):235-244. PubMed ID: 33692257
[TBL] [Abstract] [Full Text] [Related]
9. A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient pancreatic cancer.
Wang Y; Park JYP; Pacis A; Denroche RE; Jang GH; Zhang A; Cuggia A; Domecq C; Monlong J; Raitses-Gurevich M; Grant RC; Borgida A; Holter S; Stossel C; Bu S; Masoomian M; Lungu IM; Bartlett JMS; Wilson JM; Gao ZH; Riazalhosseini Y; Asselah J; Bouganim N; Cabrera T; Boucher LM; Valenti D; Biagi J; Greenwood CMT; Polak P; Foulkes WD; Golan T; O'Kane GM; Fischer SE; Knox JJ; Gallinger S; Zogopoulos G
Clin Cancer Res; 2020 Oct; 26(20):5462-5476. PubMed ID: 32816949
[TBL] [Abstract] [Full Text] [Related]
10. Para-aortic lymph node metastasis detected intraoperatively by systematic frozen section examination in pancreatic head adenocarcinoma: is resection improving the prognosis?
Collard M; Voron T; Svrcek M; Ahmed O; Balladur P; Hor T; André T; Paye F
HPB (Oxford); 2020 Nov; 22(11):1604-1612. PubMed ID: 32179009
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic cancer treated with stereotactic body radiation therapy.
Ren S; Zhu X; Zhang A; Li D; Zuo C; Zhang H
Cancer Imaging; 2020 Mar; 20(1):22. PubMed ID: 32156306
[TBL] [Abstract] [Full Text] [Related]
12. Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy.
Blair AB; Rosati LM; Rezaee N; Gemenetzis G; Zheng L; Hruban RH; Cameron JL; Weiss MJ; Wolfgang CL; Herman JM; He J
Surgery; 2018 May; 163(5):1090-1096. PubMed ID: 29395234
[TBL] [Abstract] [Full Text] [Related]
13. The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis.
Ejaz A; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss M; Marques HP; Aldrighetti L; Pawlik TM
J Surg Oncol; 2017 Dec; 116(7):841-847. PubMed ID: 28650564
[TBL] [Abstract] [Full Text] [Related]
14. Continuous Regional Arterial Infusion of Protease Inhibitors Has No Efficacy in the treatment of Severe Acute Pancreatitis: A Retrospective Multicenter Cohort Study.
Horibe M; Sasaki M; Sanui M; Sugiyama D; Iwasaki E; Yamagishi Y; Sawano H; Goto T; Ikeura T; Hamada T; Oda T; Yasuda H; Shinomiya W; Miyazaki D; Hirose K; Kitamura K; Chiba N; Ozaki T; Yamashita T; Koinuma T; Oshima T; Yamamoto T; Hirota M; Moriya T; Shirai K; Mayumi T; Kanai T
Pancreas; 2017 Apr; 46(4):510-517. PubMed ID: 27977624
[TBL] [Abstract] [Full Text] [Related]
15. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
[TBL] [Abstract] [Full Text] [Related]
16. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.
Bachet JB; Maréchal R; Demetter P; Bonnetain F; Couvelard A; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Rougier P; Penna C; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
Ann Oncol; 2012 Sep; 23(9):2327-2335. PubMed ID: 22377565
[TBL] [Abstract] [Full Text] [Related]
17. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP;
Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156
[TBL] [Abstract] [Full Text] [Related]
18. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
[TBL] [Abstract] [Full Text] [Related]
19. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration.
Sato T; Yamauchi N; Sasaki H; Takahashi M; Okamoto T; Sakamaki S; Watanabe N; Niitsu Y
Cancer Res; 1998 Apr; 58(8):1677-83. PubMed ID: 9563482
[TBL] [Abstract] [Full Text] [Related]
